Helen Torley joined Halozyme in 2014 as president and CEO. She has led the company to annual revenue of more than $350 million and a market cap of $2.6 billion.
M&A: Co. Will Operate as Armata Pharmaceuticals
Two companies, new name. San Diego-based AmpliPhi Biosciences and Marina del Rey’s C3J Therapeutics have merged, operating as Armata Pharmaceuticals, focused on antibiotic-resistant infections.
Carlsbad’s Ra Medical Systems on May 16 sued Strata Skin Sciences and its board chair. The lawsuit alleges a campaign of false and misleading statements to financial partners before, during and after Ra Medical’s initial public offering.
FOOD: Company Appeals to Millennial Tastes, Mindset
Food company Bonafide Provisions sells chicken, beef, turkey and frontier flavored broths and other bone broth-based food products in about 6,000 stores nationwide, including Jimbo’s…Naturally!, Sprouts Farmers Market and Whole Foods Market.
HEALTH: Arm of Moores Cancer Center Holds Annual Symposium
A department at UC San Diego Health’s Moores Cancer Center is known for putting on a symposium to translate groundbreaking oncology discoveries into therapeutics.
PHARMA: Acquisitions Part of CRO Consolidation Trend Locally, Nationwide
WuXi AppTec is making moves in San Diego. The Chinese pharmaceutical company earlier this month bought San Diego-based Pharmapace.
BIOTECH: BioNTech Plans to Establish a Local Research Facility
The recent acquisition of San Diego’s MabVax has been a long time coming. MabVax sold its cancer drug assets and its lab equipment to German company BioNTech, it was announced earlier this month.
BIOTECH: Co. Gets Licensing Fee From Argenx
San Diego-based Halozyme reported higher revenue and net income in first quarter results, thanks to the company’s platform technology. Looking forward, the company is heading for an inflection point.
Rob Abrams, a former executive with Boston Scientific and investor with Sanderling Ventures, will join medical device incubator Evolve MedTech as partner.
Carlsbad-based Vertiflex – maker of a device that reduces spine pressure – was acquired by Boston Scientific. The deal includes Boston Scientific paying $465 million upfront, with additional payments dependent on commercial milestones over the next three years.
medicine: Costs To Scale Up Leave Some Cos. in the Red
The heavy-hitters of San Diego medtech — Dexcom, ResMed, Tandem Diabetes Care and NuVasive — saw revenue either rise or shoot up in recent quarterly results.
A drug candidate from Poseida Therapeutics aimed at relapsed multiple myeloma has picked up an orphan drug designation.
Genomics titan Illumina has filed a patent infringement lawsuit against a BGI Group subsidiary.
Health: Company Is Working on Getting Therapeutics Into Cell
DTx Pharma, a Torrey Pines startup developing a way to make more effective RNA treatments, recently raised $3 million in Series A funding. The round included investments from previous investors, including Tech Coast Angels and Friedman Bioventure.